Cresco Labs Inc (CRLBF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Sales | 214,391 | 217,787 | 215,483 | 209,975 | 178,437 |
| Cost of Goods | 107,018 | 107,765 | 107,162 | 108,994 | 91,414 |
| Gross Profit | 107,373 | 110,022 | 108,321 | 100,981 | 87,023 |
| Operating Expenses | 87,124 | 95,230 | 372,501 | 87,103 | 71,199 |
| Operating Income | 20,267 | 15,557 | -264,018 | 14,872 | 16,238 |
| Interest Expense | 14,363 | 14,851 | 13,577 | 11,481 | 11,302 |
| Other Income | -6,772 | 10,911 | 1,735 | 12,725 | -13,536 |
| Pre-tax Income | -868 | 11,617 | -275,860 | 16,116 | -8,600 |
| Income Tax | 22,807 | 23,528 | -12,408 | 13,463 | 15,524 |
| Net Income Continuous | -23,675 | -11,911 | -263,452 | 2,653 | -24,124 |
| Minority Interests | 3,706 | 2,821 | 7,193 | 7,480 | 5,269 |
| Net Income | $-27,381 | $-14,732 | $-270,645 | $-4,827 | $-29,393 |
| EPS Basic Total Ops | -0.09 | -0.08 | -1.00 | -0.02 | -0.12 |
| EPS Basic Continuous Ops | -0.08 | -0.07 | -0.97 | 0.01 | -0.10 |
| EPS Diluted Total Ops | -0.09 | -0.08 | -1.00 | -0.02 | -0.12 |
| EPS Diluted Continuous Ops | -0.08 | -0.07 | -0.97 | 0.01 | -0.10 |
| EBITDA(a) | $32,343 | $25,045 | $-252,028 | $26,347 | $28,234 |